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Immunology of Transmissible
Gastroenteritis as Applied
to the Protection of Newborn Pigs
by Candace Anne Kindermann*
Development of effective immunity (active
or passive) to a disease by artificial means
depends on scientific knowledge of the
causative agent, pathogenesis of the disease,
and natural immune response to the disease.
Transmissible Gastroenteritis is a general-
ized viral disease of swine which causes high
death loss and morbidity in pigs less than two
weeks of age. In older swine, the disease is
very mild and may go undiagnosed. The
causative agent is a moderately pleomorphic
helical RNA virus of the family
coronaviridae. It has a cryptogram of R/1:
9/*: S/E: V10, and consists of a nucleocapsid
inside a spherical envelope with club shape
peplomeres. Only one serotype of T.G.E.
virus has been found. The virus has an
average diameter of 144nm, is heat inac-
tivated at 56° C for 45 minutes, ether and
chloroform labile, stable at pH 3, trypsin and
bile resistant, and has the ability to servive
passage through the stomach.
Pathogenesis of the disease includes a short
incubation time, with clinical signs appearing
eighteen hours to three days post exposure.
Transmission of the virus occurs by ingestion,
nasal, or airbourne means with a resulting
infection of the small intestine's columnar
epithelial cells, leading to destruction or
alteration of the cells and villous atrophy.
Destruction of the cells decreases the function
of the small intestine and leads to the
malabsorptive syndrome responsible for the
clinical signs.
Natural infection of mature swine with
T .G.E. virus stimulates development of active
immunity with recovery from the disease.
Effective active immunity develops eight to
nine days post infection and lasts for ap-
proxiamtely eighteen months. The
*Ms. Kindermann is a third year student in the College
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mechanism of active immunity to the T.G.E.
virus is not known. Two possible mechanisms
have been suggested. The first involves
continuous antibody production by the
plasma cells of the intestinal lamina propria,
primarily secretory IgA antibodies, in
response to antigenic stiumulation of the gut
by the virus. The antibodies produced (IgA
secretory), are then secreted into the in-
testinallumen and remain in close association
with the epithelial cells where they neutralize
the T.G.E. virus prior to its absorption and
infection of the cells. The second hypothesis
involves development of a resistant
population of intestinal epithelial cells.
Serum antibodies are produced in high titer,
with natural infection of mature animals,
they are not however, involved in the active
immunity process as related to protection of
the gut.
Protection for nursing pigs against T.G.E.
must be acquired passively, since rapid
replication of the virus in baby pig intestine
once exposure has occurred does not allow
enough time for active immunity to develop
before death occurs, and "safe immunogenic
agents suitable for stimulation of intestinal
immunity against T.G.E. in young pigs are
not available as yet because so little is known
about the local immune response of the in-
testines in young animals."23 Passive im-
munity in young pigs must be obtained by
ingestion of antibodies in colostrum, since
there is essentially no placental im-
munoglobulin transfer in swine. The
knowledge of protective T.G.E. antibody
passage to nursing pigs via immune sow's milk
and colostrum was first observed in the 1950's
when it was observed that baby pigs born to
sows that had been infected with T.G.E. virus
three weeks or more prior to farrowing
remained free of clinical signs of the disease
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even though the virus was present in the herd.
It was then shown through clinical studies
that "continuous intake of colostrum and
milk antibodies are required to neutralize the
ingested virus in the intestinal tract before
they can penetrate the intestinal epithelial
cells."21 Assays of the colostrum and milk
showed secretory IgA antibodies to be the
major type of antibodies present. A strong
relationship between the level of secretory IgA
and the degree of passive immunity provided
has now been shown. IgA secretory antibody
is responsible for protection of mucosal
surfaces of the body including the intestines
which it can effectively reach in the young pig
by ingestion due to its resistance to proteolytic
enzymes of the stomach. Antibodies (lgA)
first appear in the colostrum 14 days post
infection and have reached a protective level
by day 17. An antibody level of 1:8 or higher
was found to be necessary to protect nursing
pigs from virulent T .G.E. virus.
With knowledge of passive immunity
production in newborn pigs suckling immune
sows, Doyle, Bay, and Hutchings in 1953
suggested the practice of immunization of
pregnant sows to produce effective passive
protection of nursing pigs against T.G.E..
Since this first suggestion, much research has
been done with methods of immunization of
pregnant sows.
Oral vaccination of pregnant sows three
weeks prior to farrowing with gut-derived
virulent T.G.E. virus produces sufficient
secretory IgA antibody in colostrum and milk
to effectively protect newborn pigs against
T .G.E. by passive immunity for as long as the
pigs nurse the immune sow. IgA secretory
antibodies responsible for the passive im-
munity of nursing pigs, are produced locally
in the mammary gland (mechanism
unknown), and secreted in the colostrum and
milk of the sow. One theory of the mechanism
of local production of secretory IgA in the
mammary gland, is the relocation of T.G.E.
viral sensitized immunocytes from the lamina
propria of the intestine to the mammary
gland possibly via the blood or lymph, cloning
of the irnmunocytes in the mammary gland
and local production of secretory IgA an-
tibodies. "Crabbe, et aI, proposed that IgA
antibody producing cells after receiving
antigenic stimulus in the intestinal mucosa,
emigrate to extraintestinal sites where
secretory IgA antibody is produced. "20 The
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disadvantage of oral vaccination with virulent
T .G.E. virus is that it perpetuates the disease,
and may cause new sites of infection of
T.G.E. by spread, and/or spread of other
viruses as contaminants of the vaccine. These
are undesirable side effects of this method,
and have helped to push for continued in-
vestigation of other methods of vaccination.
Oral vaccination of pregnant sows with
attenuated live T .G.E. virus (high cell culture
passage) yields good production of serum
neutralization antibodies, but produces only .
slight to moderate passive immunity in
nursing pigs and only a slight decrease in
mortality and morbidity with oral exposure to
virulent T .G.E. virus. The antibodies present
in the colostrum and milk of these sows were
shown to be primarily of the IgG class. This
failure of production of passive immunity
may be due to lack of proper antigenic
stimulation of the sow's intestine due to at-
tenuation or antigenic change of the virus
itself.
I.M. or S.C. injection of a live attenuated
T .G.E. virus in pregnant sows three weeks
prior to farrowing did not provide protection
to nursing pigs against virulent T.G.E. virus,
even though it produced high levels of serum
neutralization antibodies. Assay of the
colostrum showed that the Ig were primarily
of the IgG class. The only vaccine available
(that I could find) was T.G.E. =vacR
produced by Diamond Labs. It is a modified
live virus of tissue culture origin, which is
administered I.M. at six weeks before
farrowing and again at two weeks before
farrowing. Its efficacy is questionable, as it
doesn't prevent death and morbidity but
merely decreases the severity of the disease to
some extent.
Intramammary injection of pregnant sows
with high passage T.G.E. virus has provided
little protection for nursing pigs, primarily
producing IgG antibodies in the colostrum
and milk. Inoculation with virulent virus
intramammary, has produced better effects,
but results are not consistant , protection of
nursing pigs is not predictable, and spread of
the virulent virus can occur.
Intranasal innoculation of mature swine
with attenuated T.G.E. virus (high cell
culture passage) protected the adult swine
against oral infection with virulent T.G.E.
virus. I could not, however, find any in-
formation on passive immunity in baby pigs
85
produced by intranasal inoculation of
pregnant sows at the correct time prior to
farrowing. I would like to see some research
done in this area. I feel a live t-s mutant strain
of T.G.E. could be developed for intranasal
vaccination of pregnant sows that would
replicate at 33° C only and cause an upper
respiratory infection rather than a
generalized infection. Hopefully, the viral
infection of the nasal mucosa would stimulate
the plasma cells of the nasal mucosa, in a
similar manner to what occurs in the in-
testine, with a resulting relocation of viral
sensitized lymphocytes to the mammary
gland, cloning, and local production of
secretory IgA antibodies which would pass in
the colostrum and milk to the nursing pigs
and provide them with passive immunity
against the virulent T.G.E. strain. Death
losses with this type of vaccine would be
essentially nil since there would be minimal
intestinal involvement during development of
immunity, and the vaccine would provide
protection against intestinal damage due to
infection with the virulent T.G.E. virus.
Along this same line of thought, may be the
use of recombination of a t-s mutant and the
wild strain of T.G.E. virus to gain a stable
hybrid virus with the advantages of both, to
be used for vaccine production.
Further research and more scientific
knowledge of the mechanisms of the immune
system involved with T.G.E. will need to be
discovered before an effective means of
control of the disease by vaccination can be
obtained. I hope that in the near future with
effective vaccination methods, we will be able
to include T.G.E. in the growing list of
diseases that are no longer of clinical and
economical importance.
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Common Swine Mycoplasmas
by Sally K. Kennedy·, Michele Gill, t
and Daniel O. Farrington,
D.V.M., Ph.D.:t:
Mycoplasmas are the smallest organisms
(200-300nm) that are capable of growth in
cell free medium. They are different from
bacteria in that they have no cell wall but are
bounded by a unit membrane. The typical
mycoplasma colony on solid growth medium
has the appearance of a "fried egg." Most
mycoplasmas require sterol for growth. Non-
sterol requiring mycoplasmas are placed into
the genus Acholeplasma.
Three recognized species of mycoplasmas
known to be pathogenic for swine are
Mycoplasma hyorhinis, a cause of
polyserositis and polyarthritis in 3-to-IO-week
old swine; M. hyosynouiae, a cause of
polyarthritis in swine over 10 weeks of age;
and M. hyopneumoniae (suipneumoniae), a
cause of chronic pneumonia in swine.
Acholeplasma laidlawii, A. granularun, A.
axanthum and other unclassified isolates of
the genus Acholeplasma are known to occur
in swine. Their role as possible primary
pathogens has not been made clear to date.
Mycoplasma hyorhinis Infection - Pigs
weighing 15-60 pounds (3-to-IO-weeks old)
show a polyarthritis-polyserositis as the
principle lesion associated with Mycoplasma
hyorhinis. This is also found in young adult
swine undergoing stress. Besides localizing in
preexisting pneumonias, the organism is
thought to induce a primary pneumonia in
the pig. Cell culture lines are frequently
contaminated by M. hyorhinis.
*Ms. Kennedy is a third year student in the College of
Veterinary Medicine.
tMs. Gill is a 1977 ISU graduate in Journalism and Mass
Communication.
;Dr. Farrington is a former associate professor at VMRI and is
now with Pfizer, Inc.
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The organism prefers serosal surfaces
including synovial membranes and is
maintained in a herd mainly by a chronic
infection in the upper respiratory tract of
adult swine. Transmission is by direct contact
or aerosol droplets. A febrile septicemia
followed by a polyserositis occurs when M.
hyorhinis enters the blood stream. The
primary lesion is characterized by
serofibrinous exudate on serosal membranes.
Secondary lesions include fibrous pleural,
pericardial and peritoneal adhesions. An
increased volume of clear to turbid synovial
fluid with or without large fibrin flakes is also
present.
A typical M. hyorhinis colony after 4 days
incubation is presented in figure 1. "Fried
egg" type colony morphology (up to Imm in
diameter) with no evidence of film and spots
is usual.
Mycoplasma hyosynoviae Infection - This
disease, which occurs in SO-to-200 pound pigs
(3-to-6-months old) and in young adult
swine, is usually an uncomplicated, non-
suppurative arthritis. Chronic infection of
tonsillar and pharyngeal mucosa of adult
swine is the primary way this organism is
maintained in the herd. Although the ar-
ticular cartilage appears normal, synovial
membranes become swollen, hyperemic, and
yellowish, with mild villous hypertrophy. The
affected joint characteristically shows an
increased volume of serofibrinous or
serosanguinous synovial fluid.
Agar grown colonies show typical "fried
egg" morphology and measure up to 1 mm in
diameter (Figure 2). The elevated central
area generally appears to be more prominant
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